PubMed:21740819 / 1127-1361 JSONTXT

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T4","span":{"begin":0,"end":234},"obj":"CONCLUSIONS"}],"text":"This new modified antisense oligonucleotides targeting VEGF-A can decrease VEGF-A expression and inhibit cell migration in SKOV3 ovarian cancer cells. This new oligonucleotides may be a promising therapeutic agent for ovarian cancers."}

{"project":"CoMAGC","denotations":[{"id":"T1","span":{"begin":75,"end":81},"obj":"Gene"},{"id":"E1","span":{"begin":82,"end":92},"obj":"Gene_expression"},{"id":"E2","span":{"begin":66,"end":74},"obj":"Negative_regulation"},{"id":"T2","span":{"begin":129,"end":143},"obj":"ovarian cancer"},{"id":"T3","span":{"begin":123,"end":128},"obj":"ovarian cancer"}],"relations":[{"id":"R1","pred":"themeOf","subj":"T1","obj":"E1"},{"id":"R2","pred":"themeOf","subj":"E1","obj":"E2"},{"id":"R3","pred":"CGE-decreased","subj":"T1","obj":"T2"},{"id":"R4","pred":"CCS-cancerTOnormal","subj":"T1","obj":"T2"},{"id":"R5","pred":"PT-observation","subj":"T1","obj":"T2"},{"id":"R3","pred":"IGE-unidentifiable","subj":"T1","obj":"T2"}],"text":"This new modified antisense oligonucleotides targeting VEGF-A can decrease VEGF-A expression and inhibit cell migration in SKOV3 ovarian cancer cells. This new oligonucleotides may be a promising therapeutic agent for ovarian cancers."}